Qube Research & Technologies (QRT)’s Xeris Biopharma Holdings XERS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14.4M Buy
3,089,771
+1,245,188
+68% +$5.82M 0.01% 773
2025
Q1
$10.1M Buy
1,844,583
+1,384,975
+301% +$7.6M 0.01% 861
2024
Q4
$1.56M Buy
459,608
+218,037
+90% +$739K ﹤0.01% 1576
2024
Q3
$688K Buy
241,571
+217,668
+911% +$620K ﹤0.01% 1792
2024
Q2
$53.8K Sell
23,903
-154,659
-87% -$348K ﹤0.01% 2359
2024
Q1
$395K Buy
+178,562
New +$395K ﹤0.01% 2270
2023
Q4
Sell
-53,883
Closed -$100K 4248
2023
Q3
$100K Buy
+53,883
New +$100K ﹤0.01% 2230
2022
Q3
Sell
-196,528
Closed -$303K 3057
2022
Q2
$303K Buy
196,528
+100,906
+106% +$156K ﹤0.01% 1577
2022
Q1
$245K Sell
95,622
-26,005
-21% -$66.6K ﹤0.01% 1856
2021
Q4
$356K Buy
+121,627
New +$356K ﹤0.01% 1720